Skip to content
★ Sign in to follow
RL

Robert Lamm

Savient Pharmaceuticals Inc
Total declarations
43
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€833k

Latest filing published 19 Feb 2009 for SAVIENT PHARMACEUTICALS INC, €7,025.

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

No signal scores available.

Robert Lamm: trading record in brief

Robert Lamm appears in our data through filings on Savient Pharmaceuticals Inc shares, published by SEC (Form 4). Between 8 December 2006 and 17 February 2009, the trades on record add up to 43 filings.

No open-market purchase appears, only 21 sales worth €833k. Outside the open market, there are 7 share grants and 14 option exercises. 2009 to date brings no purchases and 2 sales.

Most recently, on 19 February 2009, the filings show an open-market sale worth €7,025 in Savient Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert Lamm

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total
  • ▼
    8,839 USD0SEC
    1,548 shares@ US$5.71Common Stock, $.01 par value per shareSEC:0000950117-09-000231:0
  • ▼
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    13,603 USD0SEC
    2,230 shares@ US$6.10Common Stock, $0.1 par value per shareSEC:0000950117-09-000122:0
  • ◆
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    10,975 USD0SEC
    967 shares@ US$11.35Common Stock, $0.1 par value per shareSEC:0000950117-09-000122:1
  • ◆
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    10,272 USD0SEC
    905 shares@ US$11.35Common Stock, $0.1 par value per shareSEC:0000950117-09-000122:2
  • ◆
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    25,667 USD0SEC
    5,666 shares@ US$4.53Common Stock, $0.1 par value per shareSEC:0000950117-08-001523:0
  • ▼
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    9,206 USD0SEC
    1,910 shares@ US$4.82Common Stock, $0.1 par value per shareSEC:0000950117-08-001523:1
  • ◆
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    43,945 USD0SEC
    8,500 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001325:0
  • ◆
    SVP, Quality & Reg. AffairsExecutivesSavient Pharmaceuticals Inc
    15,567 USD0SEC
    3,011 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001325:1
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    25,200 USD0SEC
    1,255 shares@ US$20.08Common Stock, $.01 par value per shareSEC:0001230295-08-000138:0
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    91,586 USD0SEC
    4,433 shares@ US$20.66Common Stock, $.01 par value per shareSEC:0001230295-08-000086:0
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    2,648 USD0SEC
    567 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-08-000086:1
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    11,743 USD0SEC
    567 shares@ US$20.71Common Stock, $.01 par value per shareSEC:0001230295-08-000086:2
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    20,702 USD0SEC
    4,433 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000789:0
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    91,985 USD0SEC
    4,433 shares@ US$20.75Common Stock, $.01 par value per shareSEC:0001230295-07-000789:1
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    1,684 USD0SEC
    567 shares@ US$2.97Common Stock, $.01 par value per shareSEC:0001230295-07-000789:2
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    11,765 USD0SEC
    567 shares@ US$20.75Common Stock, $.01 par value per shareSEC:0001230295-07-000789:3
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    3,792 USD0SEC
    812 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000787:2
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    23,350 USD0SEC
    5,000 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000788:0
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    100,500 USD0SEC
    5,000 shares@ US$20.10Common Stock, $.01 par value per shareSEC:0001230295-07-000788:1
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    23,350 USD0SEC
    5,000 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000783:0
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    89,200 USD0SEC
    5,000 shares@ US$17.84Common Stock, $.01 par value per shareSEC:0001230295-07-000783:1
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    23,350 USD0SEC
    5,000 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000783:2
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    92,450 USD0SEC
    5,000 shares@ US$18.49Common Stock, $.01 par value per shareSEC:0001230295-07-000783:3
  • ▼
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    36,278 USD0SEC
    2,368 shares@ US$15.32Common Stock, $.01 par value per shareSEC:0001230295-07-000752:0
  • ◇
    SVP, Quality & Reg AffairsExecutivesSavient Pharmaceuticals Inc
    23,350 USD0SEC
    5,000 shares@ US$4.67Common Stock, $.01 par value per shareSEC:0001230295-07-000617:0

25 of 38 declarations